黑龙江省药品监督管理局药品生产安全延伸检查(中药材GAP符合性)检查结果通告(2025年 第9号)

Core Viewpoint - The announcement from the Heilongjiang Provincial Drug Administration confirms that Heilongjiang Sunflower Pharmaceutical Co., Ltd. has successfully passed the GAP compliance inspection for traditional Chinese medicine materials, indicating adherence to quality management standards [3]. Group 1: Compliance and Inspection Results - The inspection was conducted from November 25 to November 27, 2025, and the results showed compliance with GAP requirements [3]. - The inspection covered various traditional Chinese medicine products, including liver protection tablets and children's cough syrup, with specific details on product specifications and geographical coordinates of the production bases [3]. Group 2: Product Specifications - The liver protection tablets have a specification of 0.35g per tablet, while the children's cough syrup is equivalent to 1.77g of herbal slices per milliliter [3]. - The children's cough granules are specified at 3g per bag, all of which are registered under national drug standards [3].

黑龙江省药品监督管理局药品生产安全延伸检查(中药材GAP符合性)检查结果通告(2025年 第9号) - Reportify